Data provided by Nasdaq. Minimum 15 minutes delayed.
August 09, 2016
NantHealth Reports Strong 2016 Second-Quarter Revenues and Continued Progress on GPS Cancer and NantOS Platform
Total Quarterly Net Revenues Increased 167% to $31.5 Million from $11.8 Million Total Six-Month Net Revenues More than Doubled to $50.9 Million from $23.5 Million Raised Net Proceeds of Approximately $83.2 Million from Successful IPO in June 2016 GPS Progress: Increased to 200,000 Covered Cancer Lives with Three New Payer Agreements, Bringing Total to Six Payers Covering GPS ...
August 03, 2016
Sanford Health Selects NantHealth's eviti Platform to Deliver Efficient, Evidence-Based Oncology Decision Support for Treatment of Cancer Patients
Major U.S. health system brings award-winning comprehensive clinical decision support to the upper Midwest CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2016-- NantHealth, Inc. (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that Sanford Health, one of the largest health systems in the nation, has entered into a commercial license agreement for the use of its eviti®, the evidence...
August 02, 2016
NantHealth to Report 2016 Second-Quarter Financial Results and Host Conference Call on Tuesday, August 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 2, 2016-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2016 second quarter on Tuesday, August 9, 2016 after market close. NantHealth management will host a conference call that same day at 2 p.m. PT (5 p.m. ET) to review the company’s performance and answer questions. The conferen...
|There are currently no events scheduled.|